Pharmacognosy and pharmacobiotechnology / / Ashutosh Kar

• Autore: Kar Ashutosh
• Pubblicazione: New Delhi, : New Age International (P) Ltd., c2007
• Edizione: rev.-expanded 2nd ed.
• Descrizione fisica: 1 online resource (xvii, 879 pages) : illustrations
• Soggetto topico: Pharmaceutical biotechnology; Pharmacognosy
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: ""Cover ""; ""Preface to the Second Edition ""; ""Preface to the First Edition ""; ""Contents ""; ""Chapter 1. Introduction ""; ""1.1 Pharmacognosy-A Brief History ""; ""1.2 Importance of Natural Drug Substances ""; ""1.2.1 Serve as Extremely Useful Natural Drugs""; ""1.2.2 Provide Basic Compounds Affording Less Toxic and More Effective Drug Molecules""; ""1.2.3 Exploration of Biological-Active-Prototypes towards Newer and Better Synthetic Drugs""; ""1.2.4 Modificaton of Inactive Natural Products by Suitable Biological/Chemical Means into Potent Drugs"" ; ""1.3 Natural Drugs Substances: Cultivation and Production "" ""1.3.1 Plant Products""; ""1.3.2 Cell-Culture Techniques""; ""1.3.3 Microbial Metabolites""; ""1.3.4 Animal Derivatives""; ""1.4 Phytochemistry ""; ""1.4.1 Constituents""; ""Chapter 2. Pharmacobiotechnology ""; ""2.1 Introduction ""; ""2.2 Theory ""; ""2.2.1 Mutation, Crossing-over and Recombinant of Meiosis""; ""2.2.2 Third Revolution in Modern Medicine""; ""2.2.3 Genetic Code""; ""2.2.4 Specific Sets of Genes in Each Individual Organ""; ""2.2.5 Reverse Transcriptase (RT)""; ""2.2.6 3D-Proteins"" ; ""2.2.7 From Nervous System to Immune System""" "2.2.8 Body's Defence Mechanism""; ""2.2.9 PCR: in Forensic & Research""; ""2.2.10 DNA: in Metabolic Pathways""; ""2.2.11 Recombinant Vaccination Vector""; ""2.2.12 OKT3: Monoclonal Antibody""; ""2.3 Important Means in Biotechnology ""; ""2.3.1 Recombinant DNA (rDNA)""; ""2.3.2 Restriction Enzymes""; ""2.3.3 DNA: Ligase""; ""2.3.4 Cloning Vector""; ""2.3.5 Hybridization Probes""; ""2.3.6 Cloning Process""; ""2.4 Recombinant Proteins ""; ""2.4.1 Bacterial Systems""; ""2.4.2 Glycosylation"" ; ""2.4.3 Mammalian Tissue Culture Expression Systems""" "2.5 Biotechnology Vs Modern Pharmacy Practice ""; ""2.5.1 Human Proteins as Drugs""; ""2.5.2 New Drug Classes""; ""2.5.3 Vaccines""; ""2.5.4 New Immunodiagnostic Agents""; ""2.5.5 DNA Probes and RFLP Analysis""; ""2.5.6 Enzyme Linked Immunosorbant Assay (ELISA)""; ""2.6 Biotechnology Based Pharmaceuticals for the Millennium ""; ""2.6.1 Genetically Engineered Vaccine""; ""2.6.2 Gene Splicing and DNA Recombinant Procedures""; ""2.6.3 Antibodies in Biotechnology""; ""2.6.4 Gene Therapy""; ""2.6.5 3D Picture of the Lock and Keys"" ; ""2.7 Biotechnology and Modern Drug Discovery "" ""2.7.1 Approved Medicines""; ""2.7.2 Medicines Under Development""; ""2.7.3 Human Clone""; ""2.8 Biotechnology: Some Thought Provoking Newer Ideas ""; ""2.8.1 Potato Vaccine""; ""2.8.2 Functional Food Revolution""; ""Chapter 3. Carbohydrates ""; ""3.1 Introduction ""; ""3.2 Classification ""; ""3.2.1 Homoglycans""; ""3.2.2 Heteroglycans""; ""3.3 Carbohydrate Biogenesis ""; ""Chapter 4. Glycosides ""; ""4.1 Introduction ""; ""4.1.1 O-Glycosides""; ""4.1.2 S-Glycosides""; ""4.1.3 N-Glycosides""; ""4.1.4 C-Glycosides""; ""4.2 Classification ""; ""4.2.1 Anthracene Glycosides (or Anthraquinone Glycosides)""
• Titolo autorizzato: Pharmacognosy and pharmacobiotechnology
• ISBN: 81-224-2915-7; 9786612385704; 1-282-38570-4
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910824741603321
• Lo trovi qui: Univ. Federico II